Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, et al. Past, present, and future of Parkinson’s disease: a special essay on the 200th anniversary of the shaking Palsy. Mov Disord. 2017;32:1264–310.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mirelman A, Bonato P, Camicioli R, Ellis TD, Giladi N, Hamilton JL, et al. Gait impairments in Parkinson’s disease. Lancet Neurol. 2019;18:697–708.

Article  PubMed  Google Scholar 

Ellis TD, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Thackeray A, et al. Identifying clinical measures that most accurately reflect the progression of disability in Parkinson disease. Parkinsonism Relat Disord. 2016;25:65–71.

Article  PubMed  Google Scholar 

Tan D, Danoudis M, McGinley J, Morris ME. Relationships between motor aspects of gait impairments and activity limitations in people with Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2012;18:117–24.

Article  PubMed  Google Scholar 

Guttman M, Burkholder J, Kish SJ, Hussey D, Wilson A, DaSilva J, et al. [11 C] RTI-32 PET studies of the dopamine transporter in early dopa‐naive Parkinson’s disease: implications for the symptomatic threshold. Neurology. 1997;48:1578–83.

Article  CAS  PubMed  Google Scholar 

Grabli D, Karachi C, Welter M-L, Lau B, Hirsch EC, Vidailhet M, et al. Normal and pathological gait: what we learn from Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2012;83:979–85.

Article  PubMed  Google Scholar 

Galna B, Lord S, Burn DJ, Rochester L. Progression of gait dysfunction in incident Parkinson’s disease: impact of medication and phenotype. Mov Disord. 2015;30:359–67.

Article  CAS  PubMed  Google Scholar 

Sarter M, Albin RL, Kucinski A, Lustig C. Where attention falls: increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function. Exp Neurol. 2014;257:120–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Scott PJH, et al. Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology. 2013;81:1611–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taylor NL, Wainstein G, Quek D, Lewis SJG, Shine JM, Ehgoetz Martens KA. The contribution of noradrenergic activity to anxiety-induced freezing of gait. Mov Disord. 2022;37:1432–43.

Article  PubMed  PubMed Central  Google Scholar 

Tosserams A, Bloem BR, Ehgoetz Martens KA, Helmich RC, Kessels RPC, Shine JM, et al. Modulating arousal to overcome gait impairments in Parkinson’s disease: how the noradrenergic system may act as a double-edged sword. Transl Neurodegener. 2023;12:15.

Article  PubMed  PubMed Central  Google Scholar 

De Deurwaerdère P, Ramsay RR, Di Giovanni G. Neurobiology and neuropharmacology of monoaminergic systems. 2017.

McKay JL, Nye J, Goldstein FC, Sommerfeld B, Smith Y, Weinshenker D, et al. Levodopa responsive freezing of gait is associated with reduced norepinephrine transporter binding in Parkinson’s disease. Neurobiol Dis. 2023;179:106048.

Article  CAS  PubMed  Google Scholar 

Goldstein DS, Sharabi Y. The heart of PD: Lewy body diseases as neurocardiologic disorders. Brain Res. 2019;1702:74–84.

Article  CAS  PubMed  Google Scholar 

Chatterjee K, Choudhury S, Banerjee R, Siddique U, Sarkar S, Roy A, et al. Is peripheral alpha synuclein a marker for gait velocity in Parkinson’s disease? Neurosci Lett. 2022;786:136819.

Article  CAS  PubMed  Google Scholar 

Kim J-S, Lee K-S, Song I-U, Kim Y-I, Kim S-H, You I-R, et al. Cardiac sympathetic denervation is correlated with parkinsonian midline motor symptoms. J Neurol Sci. 2008;270:122–6.

Article  PubMed  Google Scholar 

Suzuki M, Urashima M, Oka H, Hashimoto M, Taira K. Cardiac sympathetic denervation in bradykinesia-dominant Parkinson’s disease. NeuroReport. 2007;18:1867–70.

Article  PubMed  Google Scholar 

Spiegel J, Hellwig D, Farmakis G, Jost WH, Samnick S, Fassbender K, et al. Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson’s disease. Mov Disord. 2007;22:1004–8.

Article  PubMed  Google Scholar 

Saiki S, Hirose G, Sakai K, Kataoka S, Hori A, Saiki M, et al. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci. 2004;220:105–11.

Article  PubMed  Google Scholar 

Goldstein DS, Sharabi Y, Karp BI, Bentho O, Saleem A, Pacak K, et al. Cardiac sympathetic denervation preceding motor signs in Parkinson disease. Clin Auton Res. 2007;17:118–21.

Article  PubMed  PubMed Central  Google Scholar 

Goldstein DS, Holmes C, Sewell L, Park MY, Sharabi Y. Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy. Clin Auton Res. 2012;22:57–61.

Article  PubMed  Google Scholar 

Horsager J, Okkels N, Fedorova TD, Knudsen K, Skjærbæk C, Van Den Berge N, et al. [18F] FEOBV positron emission tomography may not be a suitable method to measure parasympathetic denervation in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2022;104:21–5.

Article  CAS  PubMed  Google Scholar 

Wong CG, Stevens MC. The effects of stimulant medication on working memory functional connectivity in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2012;71:458–66.

Article  CAS  PubMed  Google Scholar 

Bengel FM, Schwaiger M. Assessment of cardiac sympathetic neuronal function using PET imaging. J Nucl Cardiol. 2004;11:603–16.

Article  PubMed  Google Scholar 

Goldstein DS. Imaging of the autonomic nervous system: focus on cardiac sympathetic innervation. Semin Neurol. Copyright© 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New … pp. 423–34.

Borghammer P. The α-Synuclein origin and Connectome Model (SOC Model) of Parkinson’s disease: explaining Motor Asymmetry, Non-motor Phenotypes, and Cognitive decline. J Parkinsons Dis. 2021;11:455.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56:33–9.

Article  CAS  PubMed  Google Scholar 

Orimo S, Kanazawa T, Nakamura A, Uchihara T, Mori F, Kakita A, et al. Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol. 2007;113:81–6.

Article  PubMed  Google Scholar 

Cook GA, Sullivan P, Holmes C, Goldstein DS. Cardiac sympathetic denervation without Lewy bodies in a case of multiple system atrophy. Parkinsonism Relat Disord. 2014;20:926.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shaw BH, Garland EM, Black BK, Paranjape SY, Shibao CA, Okamoto LE, et al. Optimal diagnostic thresholds for diagnosis of orthostatic hypotension with a sit-to-stand test. J Hypertens. 2017;35:1019–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Juraschek SP, Hu J-R, Cluett JL, Ishak A, Mita C, Lipsitz LA, et al. Effects of intensive blood pressure treatment on orthostatic hypotension: a systematic review and individual participant–based meta-analysis. Ann Intern Med. 2021;174:58–68.

Article  PubMed  Google Scholar 

Beaulieu ML, Müller MLTM, Bohnen NI. Peripheral neuropathy is associated with more frequent falls in Parkinson’s disease. Parkinsonism Relat Disord. 2018;54:46–50.

Article  PubMed  PubMed Central  Google Scholar 

Menz HB, Latt MD, Tiedemann A, San Kwan MM, Lord SR. Reliability of the GAITRite® walkway system for the quantification of temporo-spatial parameters of gait in young and older people. Gait Posture. 2004;20:20–5.

Article  PubMed